Orlena Wyatt
Gastroenterology · Locust Grove, GANPI 1851791446
Payments from drug & device makers
Across 264 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$531
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$425
- Intercept Pharmaceuticals, Inc.$321
- Ardelyx, Inc.$296
- Regeneron Healthcare Solutions, Inc.$286
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,65699%
- Gifts$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $2,103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $531 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $425 |
| Intercept Pharmaceuticals, Inc. | 10 | $321 |
| Ardelyx, Inc. | 14 | $296 |
| Regeneron Healthcare Solutions, Inc. | 11 | $286 |
| Sanofi | 8 | $215 |
| Ipsen Biopharmaceuticals, Inc | 2 | $159 |
| Phathom Pharmaceuticals, Inc. | 7 | $157 |
| Merck | 7 | $148 |
| Pfizer | 8 | $148 |
| Johnson & Johnson | 7 | $142 |
| Lilly USA, LLC | 5 | $108 |
| Ironwood Pharmaceuticals, Inc | 6 | $97 |
| Organon | 5 | $92 |
| Madrigal Pharmaceuticals | 3 | $82 |
| Bristol Myers Squibb | 4 | $77 |
| Aimmune Therapeutics, Inc. | 3 | $71 |
| Braintree Laboratories, Inc. | 3 | $62 |
| Gilead | 2 | $45 |
| Amgen | 2 | $35 |
| Mauna Kea Technologies, Inc. | 2 | $29 |
| Vivus LLC | 1 | $21 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,692 in reported general payments places this provider in the 60th percentile of 492 gastroenterology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 25 | $665,974 |
| CreonLipase/Protease/Amylase | 40 | $108,355 |
| ZenpepLipase/Protease/Amylase | 18 | $64,989 |
| LinzessLinaclotide | 61 | $60,539 |
| TrulancePlecanatide | 32 | $26,907 |
| Dexlansoprazole DrDexlansoprazole | 26 | $9,728 |
| Mesalamine ErMesalamine | 26 | $7,225 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 61 | $4,363 |
| CholestyramineCholestyramine (With Sugar) | 35 | $4,017 |
| Pantoprazole Sodium | 326 | $3,393 |
| Sucralfate | 74 | $2,441 |
| Omeprazole | 241 | $2,273 |
| Dicyclomine Hcl | 115 | $2,058 |
| Famotidine | 91 | $1,600 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 72 | $1,305 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $142 | $665,97425 claims |
| AbbVieCreon, Linzess | $2,103 | $168,894101 claims |
| Aimmune Therapeutics, Inc.Zenpep | $71 | $64,98918 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $425 | $26,90732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 492 gastroenterology providers in Georgia.
Other gastroenterology in Locust Grove
- Douglas WolfAtlanta$6.4M
- Aasim SheikhMarietta$6M
- Shahriar SedghiMacon$5.4M
- Jeffrey WilliamsAthens$2.5M
- Michael GalambosAtlanta$1.8M
- Nitin GuptaAtlanta$1.7M
- Bruce SalzbergSuwanee$1.4M
- Heba IskandarAtlanta$978K
- David RausherDecatur$907K
- Florence Hosseini AsliniaHiram$885K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.